Gabriele Pozzato
Overview
Explore the profile of Gabriele Pozzato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moy K, Khan M, Fasolato S, Pozzato G, Allam A, Onori S
Data Brief
. 2024 Dec;
57:111046.
PMID: 39678446
This paper describes an experimental dataset of used lithium-ion battery cells cycled on grid storage synthetic duty cycles to study their feasibility for second-life applications. Data were collected at the...
2.
Lanubile A, Bosoni P, Pozzato G, Allam A, Acquarone M, Onori S
Commun Eng
. 2024 Nov;
3(1):168.
PMID: 39533114
Accurate estimation of battery state of health is crucial for effective electric vehicle battery management. Here, we propose five health indicators that can be extracted online from real-world electric vehicle...
3.
Donadel N, Tesser A, Valencic E, De Martino E, Boz V, Pin A, et al.
J Immunol Methods
. 2024 May;
530:113696.
PMID: 38797274
Autoantibodies against type I interferon (IFN) are associated with a worse outcome in COVID-19. The measurement of cytokine-neutralizing autoantibodies has been limited, hindering understanding of their role in clinical practice....
4.
Mazzaro C, Bomben R, Gragnani L, Visentini M, Pozzato G, Pozzo F, et al.
Semin Hematol
. 2023 Feb;
59(4):177-182.
PMID: 36805885
Hepatitis C virus (HCV) is a hepatotropic and lymphotropic virus, responsible for both chronic hepatitis and extra-hepatic manifestations. Multiple epidemiologic, clinical, biological, and molecular studies have suggested that HCV plays...
5.
Mazzaro C, Adinolfi L, Pozzato G, Nevola R, Zanier A, Serraino D, et al.
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362478
The hepatitis B virus (HBV) infection leads to chronic hepatitis, cirrhosis, and hepatocarcinoma. However, about 20% of patients experience extrahepatic manifestations such as polyarteritis nodosa, non-rheumatoid arthritis, non-Hodgkin lymphoma, cryoglobulinemic...
6.
Tonon F, Cemazar M, Kamensek U, Zennaro C, Pozzato G, Caserta S, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406401
Background: For hepatocellular carcinoma (HCC), effective therapeutic approaches are lacking. As aberrant gene methylation is a major contributor to HCC development, demethylating drugs such as 5-azacytidine (5-Aza) have been proposed....
7.
Pozzato G, Allam A, Onori S
Data Brief
. 2022 Mar;
41:107995.
PMID: 35252504
This paper describes the experimental dataset of lithium-ion battery cells subjected to a typical electric vehicle discharge profile and periodically characterized through diagnostic tests. Data were collected at the Stanford...
8.
Mazzaro C, Quartuccio L, Adinolfi L, Roccatello D, Pozzato G, Nevola R, et al.
Viruses
. 2021 Nov;
13(11).
PMID: 34835054
Extrahepatic manifestations are a feature of chronic hepatitis C virus (HCV) infection. In the course of chronic HCV infection, about 70% of patients have one or more extrahepatic manifestations. The...
9.
Mazzaro C, Dal Maso L, Visentini M, Ermacora A, Andreone P, Gattei V, et al.
Hematol Oncol
. 2021 Sep;
39(4):439-447.
PMID: 34477233
Several studies have suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Several authors have demonstrated that pegylated interferon (Peg-IFN) plus ribavirin...
10.
Tonon F, Farra R, Zennaro C, Pozzato G, Truong N, Parisi S, et al.
Pharmaceuticals (Basel)
. 2021 Aug;
14(8).
PMID: 34451900
Hepatocellular carcinoma (HCC) is the sixth most common type of tumor and the second leading cause of tumor-related death worldwide. Liver cirrhosis is the most important predisposing factor for HCC....